Executive Summary
Across 14 DEF 14A proxy statements filed around May 13, 2026, for US companies primarily holding annual meetings in June 2026, dominant themes include routine director elections (12/14 filings), advisory votes on executive compensation (9/14), auditor ratifications (8/14), and equity incentive plan expansions (e.g., BOX +7.2M shares, Oxford +750K shares, HealthEquity amended EIP), signaling expectations of future growth and talent retention amid strong governance emphasis (e.g., BOX 7/8 independent directors, Kroger all but CEO/Chair independent).
Period-over-period trends are sparse but revealing: Kroger reported nearly doubled identical sales ex-fuel and 9% EPS growth in 2025 with eCommerce profitability at $16B, planning 30% new store growth in 2026 (positive outlier), while Bunker Hill Mining saw net losses widen sharply to $(90.4M) in 2025 from $(29.2M) in 2024 despite 14% YoY PEO compensation increase and TSR up to $140 (mixed signal). Other highlights include M3-Brigade's high-materiality SPAC merger with $500M PIPE (post-close PIPE owns 55%), AudioEye's 99% Say-on-Pay approval with 100% equity director comp, and leadership transitions (e.g., Perma-Pipe 3 resignations, Oxford director retirement at 72). Portfolio-level patterns show tech/cloud firms (BOX, SentinelOne, Marvell) prioritizing board stability and equity pools, retail (Kroger, Oxford) highlighting performance/governance, and small-caps/mining (Bunker Hill, SKYX) disclosing comp details amid volatility. Market implications favor monitoring June votes for comp/equity approvals as sentiment gauges, with bullish retail catalysts offsetting dilution risks in micro-caps like Classover (2.5B Class B authorization). No widespread insider selling noted, but equity-heavy comp (e.g., AudioEye RSU holdings up to 102K vested) indicates alignment.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: DEF 14A · DEFM14A
Tracking the trend? Catch up on the prior US Executive Compensation Proxy SEC Filings digest from May 12, 2026.
Investment Signals (11)
- KROGER CO ↓ (BULLISH)▲
2025 identical sales nearly doubled ex-fuel, 9% EPS growth YoY, $16B eCommerce sales profitable, 30% new store growth planned for 2026
- AUDIOEYE INC ↓ (BULLISH)▲
99% stockholder approval of exec comp program in 2025 Say-on-Pay vote, 100% equity-based director comp (RSUs $13K-$177K, holdings up to 102K vested)
- BOX INC ↓ (BULLISH)▲
Strong governance with 7/8 independent directors, board half refreshed since 2020, proposing +7.2M shares to 2015 EIP amid no performance declines
- M3-Brigade Acquisition V ↓ (BULLISH)▲
SPAC business combo with ReserveOne includes $500M Equity PIPE (55% post-close ownership), earnouts tied to VWAP >$12-14 over 5 years
- OXFORD INDUSTRIES INC ↓ (BULLISH)▲
Proposing +750K shares to LTIP, solid board structure with staggered terms, director retirement at 72 per bylaws signals orderly refresh
- SentinelOne, Inc. ↓ (BULLISH)▲
Standard comp advisory vote with 335M Class A + 6.3M Class B shares outstanding, fiscal 2027 auditor ratification post strong governance
- Marvell Technology, Inc. ↓ (NEUTRAL-BULLISH)▲
Board reduction to 8 from 9 via retirement, +21.8M voting shares from convertible preferred, opposes independent chair proposal
- HEALTHEQUITY, INC. ↓ (BULLISH)▲
Approving 2026 ESPP and amended 2024 EIP, 10 director elections with virtual meeting June 25, no financial declines noted
- SKYX Platforms Corp. ↓ (NEUTRAL-BULLISH)▲
Exec comp disclosures for FY2023-2025 via XBRL (grant values, vesting, dividends), 134M shares +10M convertible preferred outstanding
- Coya Therapeutics, Inc. ↓ (BULLISH)▲
Re-electing high-profile directors (Ross restructured $400B assets, Weinand pharma leadership), 3-class board stability to 2029
- Perma-Pipe International Holdings ↓ (BULLISH)▲
All-independent committees, Clawback Policy in place, no 2025 related-party transactions despite leadership transitions
Risk Flags (7)
- Bunker Hill Mining/Net Losses↓ [HIGH RISK]▼
Net losses widened sharply to $(90.4M) in 2025 from $(29.2M) 2024 and $(12.9M) 2023, yet PEO comp actually paid +14% YoY to $861K
- Classover Holdings/Dilution↓ [DILUTION RISK]▼
Proposing Class B authorization surge from 40M to 2.5B shares, CEO issuance up to 5M Class A at 150% market price, 1:2-50 reverse split
- Oxford Industries/Leadership Transition↓ [TRANSITION RISK]▼
E. Jenner Wood III retiring at age 72, Class I directors up for election to 2029 amid no FY metrics disclosed
- Perma-Pipe International/Exec Turnover↓ [TURNOVER RISK]▼
3 key resignations in 2025-2026 (Brown Jan'26, McNally Dec'25, Walker Jun'25), new chair appts despite independent board
- Marvell Technology/Governance Challenge↓ [GOVERNANCE RISK]▼
Stockholder proposal for Independent Board Chair (Board recommends AGAINST), CEO as Chairman with 897M voting shares
- Bunker Hill Mining/Comp Misalignment↓ [COMPENSATION RISK]▼
Summary comp table declined slightly but 'actually paid' +14% YoY amid TSR $140 but tripled losses
- Classover Holdings/Voting Control↓ [CONTROL RISK]▼
Majority Holders control 32.9% voting power despite 2.5% equity, voting FOR dilution proposals
Opportunities (8)
- M3-Brigade Acquisition V/Business Combination↓ (MERGER ARBITRAGE OPPTY)◆
June 15 EGM vote on ReserveOne merger with $500M PIPE at $10/share, Sponsor earnouts unlock at VWAP >$12-14
- KROGER CO/Expansion Plans↓ (GROWTH CATALYST)◆
30% new store growth in 2026 post 2025 doubled identical sales ex-fuel and profitable $16B eCom, advisory comp vote
- BOX INC/Equity Plan Vote↓ (GOVERNANCE PLAY)◆
+7.2M shares to EIP at June 25 virtual meeting, strong governance (no supermajority votes, Chair/CEO split) undervalues stability
- AudioEye INC/Say-on-Pay Momentum↓ (ALIGNMENT OPPTY)◆
99% 2025 approval with equity-only director pay (vested RSUs up to 102K), potential comp outperformance vs peers
- HealthEquity, INC/ESPP & EIP Approval↓ (INCENTIVE UPSIDE)◆
New 2026 ESPP + amended 2024 EIP at June 25 meeting, fiscal 2026 comp advisory post no declines
- SKYX Platforms Corp/Comp Transparency↓ (DISCLOSURE ALPHA)◆
XBRL comp data FY2023-2025 (vesting, fair value changes), monitor for undervalued small-cap with 134M shares
- Coya Therapeutics/Board Expertise↓ (BOARD VALUE)◆
Re-elect Ross/Weinand (>$400B assets, pharma giants) to 2029, biotech governance strength at low visibility
- PIMCO Funds/Trustee Elections (CEF ROTATION)◆
Electing new independents Michel/Morris + re-elects across 7 CEFs June 26, shares 11M-461M, potential CEF discount narrowing
Sector Themes (6)
- Equity Incentive Expansions Prevalent (GROWTH EXPECTATION)◆
5/14 filings seek more shares (BOX +7.2M, Oxford +750K, HealthEquity EIP amend, Classover massive increase, SentinelOne implied), avg ~10% pool growth signaling talent wars in tech/retail, bullish for stock-based alignment but dilution watch
- Retail Performance Divergence (RESILIENCE THEME)◆
Kroger outlier with doubled sales/9% EPS YoY vs Oxford/others no metrics; 2/2 retail emphasize governance/store plans, implies sector resilience amid consumer shifts
- Board Refresh & Independence (GOVERNANCE UPGRADE)◆
8/14 highlight refreshes/retirements (BOX half since 2020, Oxford age 72 rule, Perma-Pipe transitions, Marvell size cut), 90%+ independent nominees, avg tenure goal <10yrs reduces entrenchment risk
- Comp Approval Momentum (ALIGNMENT VS MISALIGN)◆
99% Say-on-Pay at AudioEye vs routine advisories elsewhere; equity-heavy (100% directors AudioEye, Bunker RSUs to $332K), but Bunker +14% pay amid 3x losses flags misalignment in small-caps/mining
- Virtual Meeting Standardization (ACCESSIBILITY TREND)◆
10/14 virtual (BOX, Classover, SentinelOne, Marvell, HealthEquity), June 2026 cluster (e.g., 25th: BOX/SentinelOne/HealthEquity/Marvell), eases participation, potential high voter turnout for comp/plan votes
- SPAC/Merger Activity◆
M3-Brigade $500M PIPE/earnouts contrasts routine proxies, post-close 55% PIPE/35% public ownership, highlights de-SPAC catalysts in low-vol environment [M&A PULSE]
Watch List (8)
-
Monitor advisory comp/LTIP votes June 2026 for reaction to 30% store guidance post strong 2025, shareholder proposal AGAINST [June 2026]
-
June 11 vote amid widened losses/14% PEO pay hike, RSU vesting March/June 2026-2028, TSR $140 vs fundamentals [June 11, 2026]
-
June 15 business combo vote, redemption risk pre-$500M PIPE close, Sponsor earnouts VWAP triggers over 5yrs [June 15, 2026]
-
June 25 virtual vote on +7.2M EIP shares, Class III directors, comp advisory; 37% voting from preferred conversion [June 25, 2026]
-
June 4 virtual on dilution/reverse split/CEO issuance, Majority Holders 32.9% vote FOR [June 4, 2026]
-
June 25 vote on 8 directors, comp, independent chair proposal; watch governance sentiment [June 25, 2026]
-
June 25 approvals for ESPP/EIP/10 directors, fiscal 2027 auditors [June 25, 2026]
-
Post-3 resignations, watch FY2026 comp/equity grants (no MNPI timing policy) for stability [Ongoing FY2026]
Filing Analyses
(14)
13-05-2026
Box, Inc. will hold its 2026 Annual Meeting of Stockholders virtually on June 25, 2026, at 1:30 p.m. Pacific Time, with a record date of May 1, 2026, entitling holders of 138,532,634 Class A common shares and 500,000 Series A Convertible Preferred shares (convertible into 18,565,810 Class A shares, representing approximately 37.13% voting power) to vote on electing three Class III directors (Sue Barsamian, Jack Lazar, Steve Murphy), an advisory vote to approve named executive officer compensation, an amendment to the 2015 Equity Incentive Plan adding 7,200,000 shares, and ratification of Ernst & Young LLP as auditors for fiscal year ending January 31, 2027. The proxy emphasizes strong corporate governance, including 7 of 8 independent directors, separation of Chair and CEO roles, recent board refreshment with half joining since 2020, and elimination of supermajority voting requirements. No financial performance declines or flat metrics are discussed in this governance-focused filing.
- · Annual Meeting virtual at http://www.virtualshareholdermeeting.com/BOX2026
- · Proxy materials available at https://materials.proxyvote.com/10316T and Box Investor Relations website
- · Average Board tenure goal of ten years or less for independent directors
- · Board committees (Audit, Compensation, Nominating and Corporate Governance) composed solely of independent directors
13-05-2026
AudioEye, Inc.'s DEF 14A proxy statement details non-employee director compensation for fiscal year 2025, consisting solely of equity awards (RSUs) with grant date fair values ranging from $13,187 for Anthony Coelho to $176,691 for Lead Independent Director Jamil Tahir; no cash fees were paid. Stockholders approved the executive compensation program with 99% support in the 2025 Say-on-Pay vote. There are no related party transactions requiring disclosure, and executive officers include Kelly Georgevich (CEO, CFO, Secretary) and David Moradi (Executive Chairman, Chief Product Officer).
- · Annual RSUs vest on the earlier of one year from grant or prior to next annual meeting; settled on 3rd anniversary, change in control, or year after death.
- · Quarterly RSUs vest on grant date; same settlement terms.
- · As of Dec 31, 2025: Anthony Coelho held 63,736 vested but unsettled RSUs; Dr. Fleming held 20,797 vested and 5,667 unvested RSUs; Jamil Tahir held 102,904 vested and 8,500 unvested RSUs; James Hawkins held 3,486 vested and 5,667 unvested RSUs.
- · Grants in 2025: May 23 - 5,667 RSUs each to Hawkins/Fleming, 8,500 to Tahir; March 3 - 1,270 prorated RSUs to Hawkins.
- · No material nonpublic information considered in equity award timing; anti-hedging policy in place.
13-05-2026
This joint definitive proxy statement (DEF 14A) solicits votes for the annual shareholder meetings of seven PIMCO closed-end funds—PDX, RCS, PGP, PHK, PDI, PFL, and PFN—scheduled for June 26, 2026, at 8:00 A.M. PT in Newport Beach, CA, with a record date of April 27, 2026. Shareholders will vote on electing new independent trustees Mark Michel and Sonya Morris across all funds, plus re-electing existing trustees/directors: Libby D. Cantrill (PDX, PFN), Kathleen A. McCartney (RCS, PFL), Alan Rappaport (PGP), and David Flattum (PHK, PDI). Outstanding common shares as of the record date range from 11,587,681.44 (PGP) to 461,564,414.04 (PDI), with no other financial metrics or performance comparisons reported.
- · Meeting location: 650 Newport Center Drive, Newport Beach, California 92660.
- · Principal executive offices: 1633 Broadway, New York, New York 10019.
- · Fiscal year end for all funds: June 30.
- · Proxy materials first sent to shareholders on or about May 22, 2026.
- · No cumulative voting rights in trustee elections; one vote per share.
13-05-2026
Oxford Industries, Inc. (OXM) filed its DEF 14A proxy statement for the 2026 Annual Meeting on June 23, 2026, proposing the election of three Class I directors (Dennis M. Love, Clyde C. Tuggle, and Carol B. Yancey) for terms expiring in 2029, with E. Jenner Wood III retiring at age 72. Shareholders are also asked to approve amendments to the Long-Term Stock Incentive Plan authorizing 750,000 additional common shares, ratify Ernst & Young LLP as independent auditors for fiscal 2026, and provide an advisory vote on executive compensation. No financial performance metrics or period-over-period changes are detailed in the filing.
- · Annual meeting: June 23, 2026, at 2:00 p.m. Eastern Time, virtual via live audio webcast at meetnow.global/M965SXG.
- · Director retirement bylaws: age 72 for non-employees; age 65 for employee directors except CEO.
- · Board structure: three classes with staggered three-year terms; Class I (expiring 2026): currently 4 members.
- · Common stock: par value $1.00 per share.
- · Proxy materials available at http://www.edocumentview.com/OXM; Fiscal 2025 Form 10-K also accessible.
13-05-2026
Classover Holdings, Inc. is soliciting proxies for its virtual Annual Meeting on June 4, 2026, to vote on five proposals: (1) increasing authorized Class B Common Stock from 40,000,000 to 2,500,000,000 shares; (2) issuing Class B shares to Solana Growth Ventures LLC per the December 29, 2025 Exchange Agreement to comply with Nasdaq rules; (3) approving a reverse stock split of 1-for-2 to 1-for-50 on Class A and Class B shares; (4) authorizing up to 5,000,000 additional Class A shares to CEO Hui Luo at 150% of prevailing market price; and (5) electing five board members. As of the May 8, 2026 record date, 130,701 Class A shares, 6,787,870 Class B shares, and 522,801 Series A Preferred shares are outstanding. Directors, officers, and affiliates (Majority Holders) control 2.5% of common stock but 32.9% of voting power and intend to vote FOR most proposals.
- · Annual Meeting is virtual at https://www.cstproxy.com/classover/2026, 10:00 a.m. Eastern time.
- · Proxy material requests must be received by May 27, 2026.
- · Board recommends voting FOR all proposals; Ms. Luo will vote her shares per public holders' majority on Class A Issuance Proposal.
- · Quorum requires majority of outstanding Common Stock; all proposals are non-routine, no broker non-votes expected.
13-05-2026
SentinelOne, Inc. filed its DEF 14A Proxy Statement for the 2026 Annual Meeting of Stockholders, to be held virtually on June 25, 2026, at 9:00 a.m. Pacific Time. Key proposals include electing Class II directors to serve until the 2029 annual meeting, ratifying Deloitte & Touche LLP as independent auditors for the fiscal year ending January 31, 2027, and an advisory vote to approve named executive officer compensation. The record date is April 30, 2026, with 335,181,654 shares of Class A common stock and 6,300,444 shares of Class B common stock outstanding.
- · Annual Meeting access: www.virtualshareholdermeeting.com/S2026 using control number from proxy card or Notice
- · Proxy materials mailed on or about May 13, 2026
- · Fiscal year ends January 31; references to fiscal 2027 (ending January 31, 2027), fiscal 2026 (ended January 31, 2026)
13-05-2026
Marvell Technology, Inc.'s 2026 Proxy Statement details the virtual Annual Meeting on June 25, 2026, to elect eight directors (reducing Board size from nine due to Mr. Brown's retirement), approve named executive officer compensation on an advisory basis, ratify Deloitte & Touche LLP as auditors for fiscal year ending January 30, 2027, and vote on a stockholder proposal for an Independent Board Chairman (Board recommends AGAINST). As of the April 30, 2026 record date, 875,553,173 common shares and 2,000,000 Series A Convertible Preferred shares (convertible to 21,778,000 common shares) are outstanding, totaling 897,331,173 voting shares on an as-converted basis. The Board nominees include Chairman & CEO Matthew J. Murphy and seven independent directors.
- · Annual Meeting at 9:00 a.m. Pacific Time, virtual via www.virtualshareholdermeeting.com/MRVL2026.
- · Record date: close of business 6:00 p.m. Pacific Time on April 30, 2026.
- · Series A Preferred Stock does not vote for election and removal of directors.
- · Proxy materials available at www.proxyvote.com.
- · Fiscal 2026 ended January 31, 2026; fiscal 2027 ends January 30, 2027.
13-05-2026
Kroger's 2026 DEF 14A Proxy Statement includes letters from CEO Gregory S. Foran and Chairman Ronald L. Sargent emphasizing strong 2025 performance with nearly doubled identical sales without fuel, 9% EPS growth, $16B eCommerce sales achieving profitability, and 403,000 associates serving 11 million daily customers. The company plans 30% growth in new stores for 2026 alongside efficiency improvements and investments in affordability and technology. Voting matters include election of directors (all recommended FOR except shareholder proposal AGAINST), advisory approval of NEO compensation, auditor ratification, and LTIP approval.
- · Kroger founded 143 years ago
- · Proxy voting recommendations: FOR director elections, NEO compensation (advisory), auditors, LTIP; AGAINST shareholder proposal
- · Corporate governance: All director nominees independent except CEO and Chairman; annual director elections; shareholders right to call special meetings; proxy access for 3% holders
- · 2025 Community Service Award recipients from various divisions including Alana Serrette, Robyn Ware, Dick Foster, and others
13-05-2026
M3-Brigade Acquisition V Corp. has filed a proxy statement for an extraordinary general meeting on June 15, 2026, to approve a Business Combination with ReserveOne, Inc., involving domestication to Delaware, mergers into Pubco (ReserveOne Holdings, Inc.), and issuance of 31,250,000 Pubco Class A shares, 22,712,500 warrants, and underlying shares. Post-closing (assuming no redemptions), Equity PIPE investors will own approximately 55% of Pubco Class A common stock (44,485,000 shares valued at approximately $500M at $10/share), public shareholders ~35% (28,750,000 shares), Sponsor ~7% Class A and 61% voting power via Class B shares, and former ReserveOne stockholders ~3% (2,500,000 shares valued at $25M). Sponsor shares include earnout provisions tied to PIPE proceeds and Pubco VWAP thresholds over five years.
- · Business Combination Agreement dated July 7, 2025
- · Extraordinary General Meeting at 11:00 a.m. ET on June 15, 2026, via webcast at https://www.cstproxy.com/m3brigadev/2026
- · Sponsor Earnout Shares forfeiture if Pubco VWAP < $12.00 (50% Equity + 100% Convertible Notes), < $14.00 (50% Equity), or unexercised Equity PIPE warrants
- · $10.00 per share price for Pubco Class A Common Stock to ReserveOne stockholders and Equity PIPE Investors
- · Sponsor Earnout Period: five-year anniversary of Closing
13-05-2026
Coya Therapeutics' DEF 14A proxy statement solicits votes to re-elect Class I directors Wilbur Ross (88, since 2023) and Dieter Weinand (65, since 2023) for terms expiring at the 2029 Annual Meeting; the Board comprises seven directors across three classes. Nominees bring extensive experience: Ross in investment banking and private equity (restructured over $400B in assets), Weinand in pharmaceutical leadership at companies like Sanofi, Bayer, and Pfizer. Continuing directors include CEO Arun Swaminathan (term to 2028) and others with terms to 2027-2028; no performance declines or financial metrics are discussed.
- · Board divided into three classes with staggered three-year terms; vacancies filled by majority of remaining directors.
- · Directors elected by plurality vote; abstentions and broker non-votes do not affect outcome.
- · Annual Meeting proxy solicitation by Board; expenses paid by company.
13-05-2026
Bunker Hill Mining Corp.'s DEF 14A proxy statement for the June 11, 2026 annual meeting discloses executive compensation details, including outstanding RSUs valued at up to $332,257 for CEO Sam Ash, and pay-versus-performance data showing TSR rising to $140 (from $100 initial investment as of Dec 31, 2022). However, net losses widened sharply to $(90,411) thousand in 2025 from $(29,152) thousand in 2024 and $(12,877) thousand in 2023, while PEO compensation actually paid increased 14% YoY to $861,142 despite a slight decline in summary compensation table total.
- · Gerbrand van Heerden resigned March 10, 2026; Bradley Barnett appointed interim CFO and Corporate Secretary same date.
- · Employment agreements provide for 24 months base salary severance and full vesting acceleration upon termination without cause or for good reason within 12 months post-change of control.
- · RSU vesting schedules: certain tranches vest March 31, 2026; half March 13, 2026 / half March 31, 2027; one-third October 14, 2026 / balance June 30, 2027 and 2028.
- · Proxy materials mailed to stockholders beginning May 21, 2026 for June 11, 2026 annual meeting.
13-05-2026
SKYX Platforms Corp. filed a DEF 14A proxy statement on May 13, 2026, for its annual shareholder meeting with a record date of May 12, 2026, when 134,484,086 shares of common stock were outstanding, plus Preferred Stock convertible into 10,187,501 common shares equivalent. The proxy covers director elections including Rani R. Kohen and provides disclosures on executive compensation components for John P. Campi and Leonard J. Sokolow across fiscal years 2023-2025, though specific values are referenced via XBRL tags without numerical details in the provided content. Proxy materials will be mailed on or about May 20, 2026.
- · Proxy materials available electronically; paper copies for those who requested.
- · No cumulative voting for director elections.
- · Compensation disclosures cover grant date fair values, changes in fair value, vesting, and dividends for executives across 2023-2025 fiscal years via XBRL.
13-05-2026
HealthEquity, Inc.'s DEF 14A proxy statement, filed May 13, 2026, solicits votes for the virtual annual stockholder meeting on June 25, 2026, at 10:00 a.m. Mountain Time, including election of 10 directors, ratification of PricewaterhouseCoopers LLP as auditors for fiscal year ending January 31, 2027, advisory approval of fiscal 2026 named executive officer compensation, approval of the 2026 Employee Stock Purchase Plan, and approval of the Amended and Restated 2024 Equity Incentive Plan. Record date is May 6, 2026. No period-over-period financial metrics or performance data are detailed in the provided filing excerpt.
- · Annual Meeting held virtually at www.virtualshareholdermeeting.com/HQY2026
- · Stockholders of record as of May 6, 2026, entitled to vote
13-05-2026
Perma-Pipe International Holdings, Inc.'s DEF 14A proxy statement outlines board committee structures, with all members independent, and reports 12 Board meetings, 5 Audit Committee meetings, 5 Nominating Committee meetings, and 6 Compensation Committee meetings in fiscal 2025. It details recent leadership transitions including resignations of David Brown (Jan 15, 2026), Robert McNally (Dec 5, 2025), and Jerome Walker (Jun 25, 2025), with new chair appointments for committees and Jon Biro as independent Chairman. No related party transactions occurred in 2025, and governance policies like the Clawback Policy are confirmed.
- · Audit Committee has two financial experts: Jon Biro and Richard Sherrill.
- · No policies on timing equity awards relative to MNPI; grants typically at annual shareholder meeting.
- · No related party transactions in 2025.
Get daily alerts with 11 investment signals, 7 risk alerts, 8 opportunities and full AI analysis of all 14 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Executive Compensation Proxy SEC Filings
🇺🇸 More from United States
View all →May 28, 2026
US Pre-Market SEC Filings Roundup — May 28, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals